CVI Investments, Inc. 13D and 13G filings for BriaCell Therapeutics Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-07-22 09:59 am Purchase |
2025-07-15 | 13G | BriaCell Therapeutics Corp. BCTX |
CVI Investments, Inc. | 1,000,000 5.700% |
644,114 (+180.99%) |
Filing |
| 2025-07-21 11:16 am Sale |
2025-06-30 | 13G | BriaCell Therapeutics Corp. BCTX |
CVI Investments, Inc. | 355,886 4.900% |
-133,314 (-27.25%) |
Filing |
| 2025-05-01 10:01 am Purchase |
2025-04-24 | 13G | BriaCell Therapeutics Corp. BCTX |
CVI Investments, Inc. | 489,200 8.600% |
489,200 (New Position) |
Filing |